{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T10:16:18Z","timestamp":1752228978592},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bull Exp Biol Med"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1007\/s10517-020-04997-1","type":"journal-article","created":{"date-parts":[[2020,11,22]],"date-time":"2020-11-22T05:02:43Z","timestamp":1606021363000},"page":"24-29","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Features of Myocardial Remodeling and Changes in the Blood Lipid Spectrum in Experimental Doxorubicin-Induced Cardiomyopathy and Atorvastatin Administration"],"prefix":"10.1007","volume":"170","author":[{"given":"M. G.","family":"Klinnikova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. V.","family":"Koldysheva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N. V.","family":"Tursunova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. E.","family":"Semenov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. L.","family":"Lushnikova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,11,22]]},"reference":[{"issue":"2","key":"4997_CR1","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s10517-016-3594-9","volume":"162","author":"MG Klinnikova","year":"2016","unstructured":"Klinnikova MG, Lushnikova EL, Koldysheva EV, Tolstikova TG, Sorokina IV, Yuzhik EI, Mzhelskaya MM. Cardiotoxic and Dyslipidemic Effects of Doxorubicin and Betulinic Acid Amide. Bull. Exp. Biol. Med 2016;162(2):277-282. https:\/\/doi.org\/10.1007\/s10517-016-3594-9","journal-title":"Bull. Exp. Biol. Med"},{"issue":"5","key":"4997_CR2","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/s10517-019-04419-x","volume":"166","author":"EL Lushnikova","year":"2019","unstructured":"Lushnikova EL, Molodykh OP, Nikityuk DB, Semenov DE, Klinnikova MG. Structural Analysis of the Myocardium in Experimental Anthracycline-Induced Cardiomyopathy Combined with Adrenergic Stimulation. Bull. Exp. Biol. Med. 2019;166(5):689-694. https:\/\/doi.org\/10.1007\/s10517-019-04419-x","journal-title":"Bull. Exp. Biol. Med."},{"issue":"5","key":"4997_CR3","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s10557-015-6615-4","volume":"29","author":"GD Birnbaum","year":"2015","unstructured":"Birnbaum GD, Birnbaum I, Ye Y, Birnbaum Y. Statin-Induced Cardioprotection Against Ischemia-Reperfusion Injury: Potential Drug-Drug Interactions. Lesson to Be Learnt by Translating Results From Animal Models to the Clinical Settings. Cardiovasc. Drugs Ther. 2015;29(5):461-467. https:\/\/doi.org\/10.1007\/s10557-015-6615-4","journal-title":"Cardiovasc. Drugs Ther."},{"issue":"12","key":"4997_CR4","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1136\/heartjnl-2017-312103","volume":"104","author":"HPA Anthracycline Cardiotoxicity","year":"2018","unstructured":"Henriksen PA. Anthracycline Cardiotoxicity: An Update on Mechanisms, Monitoring and Prevention. Heart. 2018;104(12):971-977. https:\/\/doi.org\/10.1136\/heartjnl-2017-312103","journal-title":"Monitoring and Prevention. Heart."},{"issue":"6","key":"4997_CR5","doi-asserted-by":"publisher","first-page":"488","DOI":"10.3109\/15376516.2012.678406","volume":"22","author":"YH Kim","year":"2012","unstructured":"Kim YH, Park SM, Kim M, Kim SH, Lim SY, Ahn JC, Song WH, Shim WJ. Cardioprotective Effects of Rosuvastatin and Carvedilol on Delayed Cardiotoxicity of Doxorubicin in Rats. Toxicol. Mech. Methods. 2012;22(6):488-498. https:\/\/doi.org\/10.3109\/15376516.2012.678406","journal-title":"Toxicol. Mech. Methods."},{"issue":"1","key":"4997_CR6","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s10557-016-6711-0","volume":"31","author":"JV McGowan","year":"2017","unstructured":"McGowan JV, Chung R, Maulik A, Piotrowska I, Walker JM, Yellon DM. Anthracycline Chemotherapy and Cardiotoxicity. Cardiovasc. Drugs. Ther. 2017;31(1):63-75. https:\/\/doi.org\/10.1007\/s10557-016-6711-0","journal-title":"Cardiovasc. Drugs. Ther."},{"key":"4997_CR7","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ijcha.2015.11.004","volume":"10","author":"MA Mitry","year":"2016","unstructured":"Mitry MA, Edwards JG. Doxorubicin induced heart failure: Phenotype and molecular mechanisms. Version 2. Int. J. Cardiol. Heart Vasc. 2016;10:17-24. https:\/\/doi.org\/10.1016\/j.ijcha.2015.11.004","journal-title":"Int. J. Cardiol. Heart Vasc."},{"issue":"7","key":"4997_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0132451","volume":"10","author":"K Nagaoka","year":"2015","unstructured":"Nagaoka K, Matoba T, Mao Y, Nakano Y, Ikeda G, Egusa S, Tokutome M, Nagahama R, Nakano K, Sunagawa K, Egashira K. A New Therapeutic Modality for Acute Myocardial Infarction: Nanoparticle-Mediated Delivery of Pitavastatin Induces Cardioprotection from Ischemia-Reperfusion Injury via Activation of PI3K\/Akt Pathway and Anti-Inflammation in a Rat Model. PLoS One. 2015;10(7):e0132451. https:\/\/doi.org\/10.1371\/journal.pone.0132451","journal-title":"PLoS One."},{"issue":"4","key":"4997_CR9","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.jacc.2007.10.009","volume":"51","author":"K Ramasubbu","year":"2008","unstructured":"Ramasubbu K, Estep J, White DL, Deswal A, Mann DL. Experimental and Clinical Basis for the Use of Statins in Patients with Ischemic and Nonischemic Cardiomyopathy. J. Am. Coll. Cardiol. 2008;51(4):415-426. https:\/\/doi.org\/10.1016\/j.jacc.2007.10.009","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"4997_CR10","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.ijcard.2010.04.008","volume":"150","author":"H Sharma","year":"2011","unstructured":"Sharma H, Pathan RA, Kumar V, Javed S, Bhandari U. Antiapoptotic Potential of Rosuvastatin Pretreatment in Murine Model of Cardiomyopathy. Int. J. Cardiol. 2011;150(2):193-200. https:\/\/doi.org\/10.1016\/j.ijcard.2010.04.008","journal-title":"Int. J. Cardiol."},{"issue":"6","key":"4997_CR11","doi-asserted-by":"publisher","first-page":"3509","DOI":"10.3892\/ijmm.2018.3572","volume":"41","author":"Y Yu","year":"2018","unstructured":"Yu Y, Jin L, Zhuang Y, Hu Y, Cang J, Guo K. Cardioprotective effect of rosuvastatin against isoproterenol-induced myocardial infarction injury in rats. Int. J. Mol. Med. 2018;41(6):3509-3516. https:\/\/doi.org\/10.3892\/ijmm.2018.3572","journal-title":"Int. J. Mol. Med."},{"issue":"6","key":"4997_CR12","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.jacc.2007.04.050","volume":"50","author":"V Zac\u00e0","year":"2007","unstructured":"Zac\u00e0 V, Rastogi S, Imai M, Wang M, Sharov VG, Jiang A, Goldstein S, Sabbah HN. Chronic Monotherapy With Rosuvastatin Prevents Progressive Left Ventricular Dysfunction and Remodeling in Dogs With Heart Failure. J. Am. Coll. Cardiol. 2007;50(6):551-557. https:\/\/doi.org\/10.1016\/j.jacc.2007.04.050","journal-title":"J. Am. Coll. Cardiol."},{"issue":"3","key":"4997_CR13","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1093\/abbs\/gmu131","volume":"47","author":"L Zhang","year":"2015","unstructured":"Zhang L, Cheng L, Wang Q, Zhou D, Wu Z, Shen L, Zhang L, Zhu J. Atorvastatin Protects Cardiomyocytes From Oxidative Stress by Inhibiting LOX-1 Expression and Cardiomyocyte Apoptosis. Acta Biochim. Biophys. Sin. (Shanghai). 2015;47(3):174-182. https:\/\/doi.org\/10.1093\/abbs\/gmu131","journal-title":"Acta Biochim. Biophys. Sin. (Shanghai)."}],"container-title":["Bulletin of Experimental Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10517-020-04997-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10517-020-04997-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10517-020-04997-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,2]],"date-time":"2020-12-02T22:52:56Z","timestamp":1606949576000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10517-020-04997-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["4997"],"URL":"https:\/\/doi.org\/10.1007\/s10517-020-04997-1","relation":{},"ISSN":["0007-4888","1573-8221"],"issn-type":[{"value":"0007-4888","type":"print"},{"value":"1573-8221","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"7 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}